|
|
|
|
|
|
|
Poster: 68
Visits: 29
Title: Recurrence Risk Reassessment (R3) Model Based On Explant Features Improves Prediction Of Hcc Recurrence Compared With Existing Models
Authors: Charlotte Costentin ,
Centre:
|
|
You must be registered to reply or comment.
|
|
RECURRENCE RISK REASSESSMENT (R3) MODEL BASED ON EXPLANT FEATURES IMPROVES PREDICTION OF HCC RECURRENCE COMPARED WITH EXISTING MODELS
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 60
Visits: 69
Title: Liver transplant, liver resection or ablation as first-line treatment for solitary HCC 3 cm or less: An intention-to-treat analysis
Authors: Tommy Ivanics , Abreu PA, Gorgen A, Claasen M, Doyle A, Muaddi H, McGilvray I, Selzner M, Beecroft R, Kachura J, Bhat M, Selzner N, Ghanekar A, Cattral M, Sayed B, Reichman T, Lilly L, Galvin Z, Sapisochin G
Centre:
|
|
|
|